Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04624880 · ClinicalTrials.gov registry record
COMT Activity and Hypnotizability
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 80
- Enrollment target
NCT04624880: Completed study, sponsored by Stanford University.
NCT04624880 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04624880 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
Hypnosis is an effective pain management tool for surgery that can reduce opioid use up to 40%. COMT single nucleotide polymorphisms (SNPs) can predict pain sensitivity and opioid use perioperatively, and may also be associated with hypnotizability or response to hypnotic analgesia. Analyzing COMT haplotypes from DNA extracted from saliva or blood using a giant magnetoresistive (GMR) nanotechnology platform may be faster, less expensive, and at least as accurate as pyrosequencing. This study aims to validate a multi-SNP point-of-care (POC) GMR assay for the rapid genotyping of SNPs predictive of COMT activity, and test the feasibility of using COMT activity as a biomarker for hypnotizability and/or response to hypnotic analgesia.
Interventions
- DEVICE Giant magnetoresistive sensor (GMR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2021-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04624880
The ClinicalTrials.gov registry entry for NCT04624880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Giant magnetoresistive sensor (GMR) is the first listed.
NCT04624880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04624880 about?
NCT04624880 is a clinical study titled "COMT Activity and Hypnotizability". Hypnosis is an effective pain management tool for surgery that can reduce opioid use up to 40%. COMT single nucleotide polymorphisms (SNPs) can predict pain sensitivity and opioid use perioperatively, and may also be associated with hypnotizability or response to hypnotic analgesia. Analyzing COMT h...
What is the current status of trial NCT04624880?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2021-01-13. Estimated completion is 2021-07-13.
What interventions are being tested in trial NCT04624880?
The interventions under investigation include: Giant magnetoresistive sensor (GMR) (DEVICE).
Who is sponsoring clinical trial NCT04624880?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.